Warburg Pincus Private Equity IX, L.P.
CIK 1332737 · last filed 2020-11-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARMK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Vital Energy, Inc. (LPI) Delisted | Director | 2,297,392 | $48.09 | $110.48M | -$2.67B | 6 | 2020-11-20 |
| ARMK | Director | 6,517,070 | $54.22 | $353.36M | -$6.16B | 3 | 2015-05-29 |
| BLDR | 10%+ Owner | 24,613,907 | $67.58 | $1.66B | $6.67M | 3 | 2012-03-09 |
| Ceres, Inc. (CERE) Delisted | Director | 288,462 | $44.96 | $12.97M | $0 | 1 | 2012-02-28 |
| FIS | Director | 41,124,148 | $40.03 | $1.65B | $0 | 2 | 2011-09-07 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2011-05-16 |
| Metavante Technologies, Inc. (MV) Delisted | 10%+ Owner | 29,779,553 | — | — | $0 | 1 | 2008-12-16 |
| NYFIX INC (NYFX) Delisted | 10%+ Owner | 3,325,227 | — | — | $313.5K | 2 | 2008-07-02 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-12-21 | Vital Energy, Inc. (LPI) Delisted | Other (J) | +1,136,703,960 | $0 | EDGAR |
| 2011-09-07 | FIS | Grant (A) | +390,960 | $3.9K | EDGAR |
| 2011-05-16 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | U | −160,352,416 | -$801.76M | EDGAR |
| 2010-09-17 | FIS | Grant (A) | +692,397 | $6.9K | EDGAR |
| 2008-12-16 | Metavante Technologies, Inc. (MV) Delisted | Other (J) | +23,580 | $236 | EDGAR |
| 2008-07-02 | NYFIX INC (NYFX) Delisted | Other (J) | +3,675,000 | $0 | EDGAR |
| 2008-03-12 | BLDR | Buy (P) | +248,654 | $1.62M | EDGAR |
| 2008-03-11 | NYFIX INC (NYFX) Delisted | Buy (P) | +79,800 | $313.5K | EDGAR |
| 2007-03-16 | BLDR | Buy (P) | +277,095 | $4.55M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.